Andrew Saik - May 28, 2021 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Signature
/s/ Mutya Harsch, attorney-in-fact for Andrew Saik
Stock symbol
VYNE
Transactions as of
May 28, 2021
Transactions value $
$10,130
Form type
4
Date filed
6/2/2021, 04:31 PM
Next filing
Jun 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Award $10.1K +3.02K +2.66% $3.36 116K May 28, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2020 and ending on May 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on May 28, 2021 (the last trading day of the offering period).